TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr | ₹4,892 Cr |
What is the latest Total Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹4,717 Cr |
| Mar2024 | ₹5,425 Cr |
| Mar2023 | ₹5,447 Cr |
| Mar2022 | ₹4,415 Cr |
| Mar2021 | ₹4,892 Cr |
How is Total Current Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,717 Cr | -13.05 | |
| Mar2024 | ₹5,425 Cr | -0.40 | |
| Mar2023 | ₹5,447 Cr | 23.38 | |
| Mar2022 | ₹4,415 Cr | -9.74 | |
| Mar2021 | ₹4,892 Cr | - | |
Compare Total Current Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹133,608.8 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
| MANKIND PHARMA | ₹91,927.6 Cr | -0.7% | 2.8% | -23.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.3% |
3.9% |
19.2% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses